Registration number:
Ryburn Pharmacy (Ripponden) Limited
for the
Year Ended 31 January 2024
Ryburn Pharmacy (Ripponden) Limited
Contents
Balance Sheet |
|
Notes to the Unaudited Financial Statements |
Ryburn Pharmacy (Ripponden) Limited
Balance Sheet
as at 31 January 2024
Note |
2024 |
2023 |
|
Fixed assets |
|||
Tangible assets |
|
|
|
Current assets |
|||
Stocks |
|
|
|
Debtors |
|
|
|
Cash at bank and in hand |
|
|
|
|
|
||
Creditors: Amounts falling due within one year |
( |
( |
|
Net current assets |
|
|
|
Total assets less current liabilities |
|
|
|
Provisions for liabilities |
( |
( |
|
Net assets |
|
|
|
Capital and reserves |
|||
Allotted, called up and fully paid share capital |
|
|
|
Profit and loss account |
|
|
|
Shareholders' funds |
|
|
Registration number: 04952659
Ryburn Pharmacy (Ripponden) Limited
Balance Sheet
as at 31 January 2024 (continued)
For the financial year ending 31 January 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Directors' responsibilities:
• |
|
• |
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts. |
These financial statements have been prepared in accordance with the special provisions relating to companies subject to the small companies regime within Part 15 of the Companies Act 2006.
These financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime and the option not to file the Profit and Loss Account has been taken.
Approved and authorised by the
......................................... |
Ryburn Pharmacy (Ripponden) Limited
Notes to the Unaudited Financial Statements
for the
Year Ended 31 January 2024
General information |
The company is a private company limited by shares incorporated in England within the United Kingdom.
The company's registration number is 04952659.
The address of its registered office is:
The principal place of business is:
Hirst Wood
Ripponden
Sowerby Bridge
West Yorkshire
HX6 4BN
Accounting policies |
Summary of significant accounting policies and key accounting estimates
The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.
Statement of compliance
These financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A smaller entities - 'The Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland' and the Companies Act 2006 (as applicable to companies subject to the small companies' regime).
Basis of preparation
These financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.
Ryburn Pharmacy (Ripponden) Limited
Notes to the Unaudited Financial Statements
for the
Year Ended 31 January 2024
(continued)
2 |
Accounting policies (continued) |
Revenue recognition
Turnover comprises the fair value of the consideration received or receivable for the sale of goods in the ordinary course of the company’s activities. Turnover is shown net of value added tax, returns, rebates and discounts.
Turnover from the sale of goods is recognised when the significant risks and rewards of ownership of the goods have been transferred to the buyer.
Tax
Current tax represents the amount of tax payable or receivable in respect of the taxable profit (or loss) for the current or past reporting periods. It is measured at the amount expected to be paid or recovered using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.
Deferred tax is recognised on temporary differences arising between the tax bases of assets and liabilities and their carrying amounts in the financial statements and on unused tax losses or tax credits in the company. Deferred tax is determined using tax rates and laws that have been enacted or substantively enacted by the reporting date.
Tangible assets
Tangible assets are stated in the balance sheet at cost (or deemed cost), less any accumulated depreciation and accumulated impairment losses.
The cost of tangible assets includes directly attributable incremental costs incurred in their acquisition and installation.
Depreciation
Depreciation is charged so as to write off the cost of assets, other than land and properties under construction over their estimated useful lives, as follows:
Asset class |
Depreciation method and rate |
Fixtures, fittings and equipment |
15% per annum on a reducing balance basis and 33.33% per annum on a straight line basis |
Leasehold property improvements |
Straight line over the life of the lease |
Stocks
Stocks are stated at the lower of cost and estimated selling price less costs to complete and sell. Cost is determined using the first-in, first-out (FIFO) method. Provision is made for damaged, obsolete and slow-moving stock where appropriate.
Ryburn Pharmacy (Ripponden) Limited
Notes to the Unaudited Financial Statements
for the
Year Ended 31 January 2024
(continued)
2 |
Accounting policies (continued) |
Leases
Rentals in which substantially all the risks and rewards of ownership are retained by the lessor are classified as operating leases. Payments made under operating leases are charged to the profit and loss account on a straight-line basis over the period of the lease.
Staff numbers |
The average number of persons employed by the company (including directors) during the year was
Tangible assets |
Leasehold property improvements |
Furniture, fittings and computer equipment |
Total |
|
Cost |
|||
At 1 February 2023 |
|
|
|
At 31 January 2024 |
|
|
|
Depreciation |
|||
At 1 February 2023 |
|
|
|
Charge for the year |
|
|
|
At 31 January 2024 |
|
|
|
Net book value |
|||
At 31 January 2024 |
|
|
|
At 31 January 2023 |
|
|
|
Ryburn Pharmacy (Ripponden) Limited
Notes to the Unaudited Financial Statements
for the
Year Ended 31 January 2024
(continued)
Debtors |
Current |
2024 |
2023 |
Trade debtors |
|
|
Prepayments |
|
|
Other debtors |
|
|
|
|
Creditors |
2024 |
2023 |
|
Due within one year |
||
Trade creditors |
|
|
Taxation and social security |
- |
|
Corporation tax liability |
46,073 |
36,759 |
Accruals and deferred income |
|
|
Other creditors |
|
|
Directors' loan accounts |
93,463 |
92,327 |
|
|
Financial commitments, guarantees and contingencies |
Amounts not provided for in the balance sheet
The total amount of financial commitments not included in the balance sheet is £